Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition

Abstract

Background: Currently approved Alzheimer’s disease medications mainly comprise acetylcholinesterase inhibitors. Many of these inhibitors are either natural compounds or synthetic molecules inspired in natural compounds. Hybrids molecules that can interact with different target sites of the enzyme could lead to the discovery of effective multitarget drugs. Objective: Design, synthesize and evaluate a series of new aza-resveratrol analogues as in vitro acetyl- and butyrylcholinesterase inhibitors. Method: The synthesis is achieved by a simple and efficient microwave-assisted method, from commercially available starting materials. Compounds are designed as hybrids of an aza-stilbene nucleus (Schiff base) connected to a tertiary amine by a hydrocarbon chain of variable length, designed to interact both with the peripheric anionic site and the catalytic site of the enzyme. Results: All the derivatives inhibit both enzymes in a concentration dependent manner, acting as moderate to potent cholinesterase inhibitors. The most potent inhibitors are compounds 12b (IC50 = 0.43 µM) and 12a (IC50 = 0.31 µM) for acetyland butyrylcholinesterase, respectively. Compounds 12a and 12b also exhibit significant acetylcholinesterase inhibition in SH-SY5Y human neuroblastoma cells without cytotoxic properties. Enzyme kinetic studies and molecular modelling reveal that inhibitor 12b targets both the catalytic active site and the peripheral anionic site of acetylcholinesterase what makes it able to modulate the self-induced β-amyloid aggregation. Furthermore, the molecular modelling analysis helps to assess the impact of the linker length in the inhibitory activity of this family of new cholinesterase inhibitors. Conclusion: These compounds have potential to serve as a dual binding site inhibitor and might provide a useful template for the development of new anti- Alzheimer’s disease agents.

New Synthetic Caffeine Analogs as Modulators of the Cholinergic System

“…On the other hand, theophylline inhibited the enzymatic activity, similar to that we reported for caffeine but with about one fifth the potency (Table 1). As a reference compound we analyzed the inhibition of AChE activity by tacrine, a potent AChE inhibitor (Biscussi et al, 2020).…”

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

“…In particular, the nano-incapsulation in lipid carriers or liposomes as well as the insertion into polymeric particles could ameliorate both pharmacodynamics and pharmacokinetics of resveratrol ( Andrade et al, 2018 ). Moreover, some efforts have been made to synthesize various analogues of resveratrol with a more potent biological activity ( Lee et al, 2012 ; Lu et al, 2013 ; Biscussi et al, 2020 ).…”

Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides

“…Recently, materials based on arginine-substituted poly(gallic acid) have been described and showed antimicrobial activity against both Gram-negative and Gram-positive bacteria 18 . Besides, cationic amino resveratrol (RES) derivatives, imine-RES, or aza-RES analogues have been prepared for different therapeutic uses, such as neurodegenerative diseases, 19 cancer 20–25 , or inflammation 16 , 17 . 3′-Amino methylated RES derivatives showed toxicity against Leishmania infantum and low toxicity when tested on normal haemopoietic cells 26 .…”